2022
DOI: 10.1016/j.athoracsur.2021.04.095
|View full text |Cite
|
Sign up to set email alerts
|

Outcome and Cost of Nurse-Led vs Perfusionist-led Extracorporeal Membrane Oxygenation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
17
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(17 citation statements)
references
References 21 publications
0
17
0
Order By: Relevance
“…Some literature shows that nurse‐led ECMO management has no difference in survival compared to perfusion‐led ECMO management and may have cost benefits. 14 …”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Some literature shows that nurse‐led ECMO management has no difference in survival compared to perfusion‐led ECMO management and may have cost benefits. 14 …”
Section: Discussionmentioning
confidence: 99%
“…Its simplicity of use allowed our MICU nurses to quickly become comfortable with the set‐up and were able to adjust settings as necessary. Some literature shows that nurse‐led ECMO management has no difference in survival compared to perfusion‐led ECMO management and may have cost benefits 14 …”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…How the team is ultimately built depends on the structure of the hospital and intensive care unit. 46 , 47 , 48 The number of interventions carried out and the orientation of the department (adult, pediatric or neonatal, cardiac, respiratory or both) also influence the size of the team and the need for training and further education. Center volume versus outcome relationship in ECLS is also controversial and there are conflicting studies on how close this relationship is.…”
Section: Ecls As a Team Approachmentioning
confidence: 99%
“…For patients with acute respiratory distress syndrome (ARDS) or severe cardiogenic shock, extracorporeal membrane oxygenation (ECMO) is a highly complex life-saving therapy that provides oxygen to their bodies, allowing their hearts and lungs to recover. 1 Though effective for the care of patients with ARDS secondary to COVID-19, ECMO therapy for more than 10 days often costs patients more than $1,000,000 and requires close monitoring by highly skilled health care professionals. 1 , 2 Over the last 2.5 years, nearly 80 million Americans contracted COVID-19, leading to high numbers of patients with ARDS needing ECMO.…”
mentioning
confidence: 99%